PL2379501T3 - Sposób wytwarzania estrów aktywowanych - Google Patents

Sposób wytwarzania estrów aktywowanych

Info

Publication number
PL2379501T3
PL2379501T3 PL09802171T PL09802171T PL2379501T3 PL 2379501 T3 PL2379501 T3 PL 2379501T3 PL 09802171 T PL09802171 T PL 09802171T PL 09802171 T PL09802171 T PL 09802171T PL 2379501 T3 PL2379501 T3 PL 2379501T3
Authority
PL
Poland
Prior art keywords
activated esters
preparing activated
preparing
esters
activated
Prior art date
Application number
PL09802171T
Other languages
English (en)
Other versions
PL2379501T4 (pl
Inventor
Antony Bigot
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of PL2379501T3 publication Critical patent/PL2379501T3/pl
Publication of PL2379501T4 publication Critical patent/PL2379501T4/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/46—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with hetero atoms directly attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/36—Oxygen or sulfur atoms
    • C07D207/40—2,5-Pyrrolidine-diones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/70—Sulfur atoms
    • C07D213/71—Sulfur atoms to which a second hetero atom is attached
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pyrrole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL09802171T 2008-12-17 2009-12-15 Sposób wytwarzania estrów aktywowanych PL2379501T4 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0807090A FR2939795B1 (fr) 2008-12-17 2008-12-17 Procede de preparation d'esters actives
EP09802171.0A EP2379501B1 (fr) 2008-12-17 2009-12-15 Procede de preparation d'esters actives
PCT/FR2009/052528 WO2010076474A1 (fr) 2008-12-17 2009-12-15 Procede de preparation d'esters actives

Publications (2)

Publication Number Publication Date
PL2379501T3 true PL2379501T3 (pl) 2014-07-31
PL2379501T4 PL2379501T4 (pl) 2014-12-31

Family

ID=40614691

Family Applications (1)

Application Number Title Priority Date Filing Date
PL09802171T PL2379501T4 (pl) 2008-12-17 2009-12-15 Sposób wytwarzania estrów aktywowanych

Country Status (25)

Country Link
US (1) US8314244B2 (pl)
EP (1) EP2379501B1 (pl)
JP (1) JP5467111B2 (pl)
KR (1) KR101645051B1 (pl)
CN (1) CN102292318B (pl)
AU (1) AU2009334689B2 (pl)
BR (1) BRPI0922972B1 (pl)
CA (1) CA2747105C (pl)
CY (1) CY1115035T1 (pl)
DK (1) DK2379501T3 (pl)
ES (1) ES2459918T3 (pl)
FR (1) FR2939795B1 (pl)
HR (1) HRP20140368T1 (pl)
IL (1) IL213525A (pl)
ME (1) ME01827B (pl)
MX (1) MX2011006624A (pl)
MY (1) MY156761A (pl)
PL (1) PL2379501T4 (pl)
PT (1) PT2379501E (pl)
RS (1) RS53267B (pl)
RU (1) RU2506258C2 (pl)
SG (1) SG172179A1 (pl)
SI (1) SI2379501T1 (pl)
SM (1) SMT201400061B (pl)
WO (1) WO2010076474A1 (pl)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2963007B1 (fr) 2010-07-26 2013-04-05 Sanofi Aventis Derives anticancereux, leur preparation et leur application therapeutique
US11352325B2 (en) 2011-09-28 2022-06-07 Waters Technologies Corporation Rapid fluorescence tagging of glycans and other biomolecules with enhanced MS signals
US10436790B2 (en) 2011-09-28 2019-10-08 Waters Technologies Corporation Rapid fluorescence tagging of glycans and other biomolecules with enhanced MS signals
JP6774748B2 (ja) * 2014-08-13 2020-10-28 ウオーターズ・テクノロジーズ・コーポレイシヨン 強められたｍｓ信号を有するグリカンおよび他の生体分子の迅速蛍光タグ付け
WO2016069764A1 (en) 2014-10-30 2016-05-06 Waters Technologies Corporation Methods for the rapid preparation of labeled glycosylamines and for the analysis of glycosylated biomolecules producing the same
WO2016077548A1 (en) 2014-11-13 2016-05-19 Waters Technologies Corporation Methods for liquid chromatography calibration for rapid labeled n-glycans
US11035832B2 (en) 2016-06-21 2021-06-15 Waters Technologies Corporation Methods of electrospray ionization of glycans modified with amphipathic, strongly basic moieties
CN109641846A (zh) 2016-06-21 2019-04-16 沃特世科技公司 通过用于增强的ms信号的还原胺化的聚糖和其他生物分子的荧光标记
EP3479103B1 (en) 2016-07-01 2022-04-20 Waters Technologies Corporation Methods for the rapid preparation of labeled glycosylamines from complex matrices using molecular weight cut off filtration and on-filter deglycosylation

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5710101B2 (pl) * 1972-10-24 1982-02-24
US5892057A (en) 1997-09-18 1999-04-06 Pierce Chemical Company Preparation of sulfo-N-hydroxysuccinimide salts
US5872261A (en) 1997-09-18 1999-02-16 Pierce Chemical Company Preparation of sulfo-N- hydroxy succinimide salts with intermediate formation of diester
JP2002316987A (ja) * 2001-04-20 2002-10-31 Sankyo Co Ltd ２−アルコキシベンゼン誘導体を含有する医薬
JP2006500364A (ja) * 2002-08-16 2006-01-05 イムノージェン インコーポレーテッド 高い反応性と溶解度を有する架橋剤および小分子薬物の標的化送達用コンジュゲートの調製におけるそれらの使用
JP4929461B2 (ja) * 2004-10-29 2012-05-09 国立大学法人富山大学 高蛍光量子収率型疎水性蛍光プローブ、それを用いる生体高分子検出法ならびに生体高分子間相互作用検出法
DE602005022108D1 (de) * 2004-11-09 2010-08-12 Basf Se N-substituierte imide als polymerisatiosinitiatoren
US8871720B2 (en) * 2005-07-07 2014-10-28 Seattle Genetics, Inc. Monomethylvaline compounds having phenylalanine carboxy modifications at the C-terminus

Also Published As

Publication number Publication date
BRPI0922972A8 (pt) 2018-02-06
AU2009334689B2 (en) 2015-10-08
HK1163664A1 (zh) 2012-09-14
CA2747105C (fr) 2017-02-28
FR2939795B1 (fr) 2010-12-17
MX2011006624A (es) 2011-11-04
AU2009334689A1 (en) 2011-07-07
CY1115035T1 (el) 2016-12-14
DK2379501T3 (da) 2014-04-28
IL213525A (en) 2014-11-30
HRP20140368T1 (hr) 2014-06-20
EP2379501A1 (fr) 2011-10-26
MY156761A (en) 2016-03-31
BRPI0922972B1 (pt) 2021-06-01
IL213525A0 (en) 2011-07-31
JP5467111B2 (ja) 2014-04-09
JP2012512234A (ja) 2012-05-31
CA2747105A1 (fr) 2010-07-08
KR101645051B1 (ko) 2016-08-02
ME01827B (me) 2014-12-20
RU2011129652A (ru) 2013-01-27
WO2010076474A1 (fr) 2010-07-08
SI2379501T1 (sl) 2014-05-30
RU2506258C2 (ru) 2014-02-10
CN102292318A (zh) 2011-12-21
RS53267B (sr) 2014-08-29
FR2939795A1 (fr) 2010-06-18
CN102292318B (zh) 2014-01-01
US20110313168A1 (en) 2011-12-22
BRPI0922972A2 (pt) 2015-08-11
PL2379501T4 (pl) 2014-12-31
KR20110094311A (ko) 2011-08-23
ES2459918T3 (es) 2014-05-12
SMT201400061B (it) 2014-07-07
EP2379501B1 (fr) 2014-01-22
US8314244B2 (en) 2012-11-20
PT2379501E (pt) 2014-05-02
SG172179A1 (en) 2011-07-28

Similar Documents

Publication Publication Date Title
PT2096102E (pt) Processo para a produção de metileno-difenil-diisocianatos
ZA201202299B (en) Method for decreasing immunigenicity
PL2252691T3 (pl) Sposób otrzymywania alfa-santalenu
GB0803107D0 (en) Method
GB0810418D0 (en) Method
IL213525A0 (en) Method for preparing activated esters
GB0804981D0 (en) Method
EP2357164A4 (en) PROCESS FOR THE PRODUCTION OF A -SUBSTITUTED ESTER
GB0807409D0 (en) Method
GB0804690D0 (en) Method
GB0813599D0 (en) Method
GB0815428D0 (en) Method
GB0807410D0 (en) Method
GB0809404D0 (en) Method
IL210051A0 (en) Method for producing aminobiphenylene
TWI350280B (en) Method for refining glycerin
IL211410A0 (en) Method for preparing nebivolol
GB0813494D0 (en) Method
GB0812559D0 (en) Method
GB0805862D0 (en) Method
EP2246322A4 (en) PROCESS FOR PRODUCING FLUORO-AMINO ACIDS
IL210353A0 (en) Method for producing phenylalkane - 1 - ols
GB0812102D0 (en) Method
GB0806186D0 (en) Method
PT2121679E (pt) Método para a produção de ésteres de azoniaspironortropina